On September 18, Rivkin Radler’s Jeff Kaiser will participate on a panel at Practising Law Institute’s Life Sciences 2025: Navigating Legal Challenges in Drug and Device Industries. Jeff’s panel is entitled “Enforcement Trends Impacting the Drug and Device Industries.”
Held at PLI’s NY Conference Center, located at 1177 Avenue of the Americas, the program will discuss the significant changes the agencies and legal regimes governing the life sciences industry have experienced under the new Trump administration. How do shifts in agency staffing, organization, and priorities affect regulatory strategy, compliance, and enforcement? How are tariffs and other international trade changes affecting life sciences companies? What are the legal, regulatory, and commercial risks involved in life sciences transactions involving AI? How are new drug pricing authorities being implemented, and how is the legal landscape for coverage and reimbursement evolving? What are the key elements of an effective compliance program?
For information and to register, click here.
Sign up to receive Rivkin Rounds at www.RivkinRounds.com.